CM Hospitalar S/A Past Earnings Performance
Past criteria checks 0/6
CM Hospitalar S/A's earnings have been declining at an average annual rate of -1.5%, while the Healthcare industry saw earnings growing at 21.6% annually. Revenues have been growing at an average rate of 25.3% per year.
Key information
-1.5%
Earnings growth rate
-6.2%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 25.3% |
| Return on equity | -2.0% |
| Net Margin | -0.5% |
| Next Earnings Update | 20 Mar 2025 |
Recent past performance updates
Recent updates
There Is A Reason CM Hospitalar S/A's (BVMF:VVEO3) Price Is Undemanding
Oct 17
Capital Allocation Trends At CM Hospitalar S/A (BVMF:VVEO3) Aren't Ideal
Jul 30CM Hospitalar S/A (BVMF:VVEO3) Looks Inexpensive After Falling 32% But Perhaps Not Attractive Enough
Jun 25CM Hospitalar S/A (BVMF:VVEO3) Not Doing Enough For Some Investors As Its Shares Slump 49%
May 11CM Hospitalar S/A (BVMF:VVEO3) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Analysts Are Updating Their CM Hospitalar S/A (BVMF:VVEO3) Estimates After Its Annual Results
Mar 29Why Investors Shouldn't Be Surprised By CM Hospitalar S/A's (BVMF:VVEO3) 28% Share Price Plunge
Mar 27Here's Why CM Hospitalar S/A (BVMF:VVEO3) Has A Meaningful Debt Burden
Jan 15Here's What To Make Of CM Hospitalar S/A's (BVMF:VVEO3) Decelerating Rates Of Return
Dec 14CM Hospitalar S/A (BVMF:VVEO3) Has More To Do To Multiply In Value Going Forward
Jun 07Returns On Capital Signal Tricky Times Ahead For CM Hospitalar S/A (BVMF:VVEO3)
Jan 16Be Wary Of CM Hospitalar S/A (BVMF:VVEO3) And Its Returns On Capital
Aug 31Statutory Earnings May Not Be The Best Way To Understand CM Hospitalar S/A's (BVMF:VVEO3) True Position
May 17Pinning Down CM Hospitalar S/A's (BVMF:VVEO3) P/E Is Difficult Right Now
Dec 09Revenue & Expenses Breakdown
How CM Hospitalar S/A makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 11,570 | -61 | 1,436 | 0 |
| 30 Jun 24 | 11,462 | 183 | 1,239 | 0 |
| 31 Mar 24 | 11,242 | 326 | 1,171 | 0 |
| 31 Dec 23 | 11,084 | 360 | 1,133 | 0 |
| 30 Sep 23 | 10,805 | 162 | 1,095 | 0 |
| 30 Jun 23 | 10,234 | 209 | 1,076 | 0 |
| 31 Mar 23 | 9,647 | 200 | 985 | 0 |
| 31 Dec 22 | 8,747 | 260 | 869 | 0 |
| 30 Sep 22 | 7,741 | 278 | 761 | 0 |
| 30 Jun 22 | 6,963 | 286 | 764 | 0 |
| 31 Mar 22 | 6,634 | 458 | 732 | 0 |
| 31 Dec 21 | 6,219 | 395 | 673 | 0 |
| 30 Sep 21 | 6,031 | 372 | 656 | 0 |
| 30 Jun 21 | 5,746 | 337 | 519 | 0 |
| 31 Mar 21 | 5,055 | 136 | 458 | 0 |
| 31 Dec 20 | 4,413 | 122 | 423 | 0 |
| 31 Dec 19 | 3,003 | 36 | 317 | 0 |
| 31 Dec 18 | 2,641 | 34 | 248 | 0 |
| 31 Dec 17 | 1,696 | 59 | 117 | 0 |
| 31 Dec 16 | 1,148 | 165 | 84 | 0 |
| 31 Dec 15 | 998 | -1 | 79 | 0 |
| 31 Dec 14 | 866 | 3 | 57 | 0 |
| 31 Dec 13 | 720 | 3 | 63 | 0 |
Quality Earnings: VVEO3 is currently unprofitable.
Growing Profit Margin: VVEO3 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VVEO3 is unprofitable, and losses have increased over the past 5 years at a rate of 1.5% per year.
Accelerating Growth: Unable to compare VVEO3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VVEO3 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (64.3%).
Return on Equity
High ROE: VVEO3 has a negative Return on Equity (-2.03%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 08:15 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CM Hospitalar S/A is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fred Mendes | BofA Global Research |
| Gustavo Tiseo | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |